MEIP has AML data OS > 22 months, which is a very very good one. The stock goes died since mid 2015 because of another drug phase 2 failure. The AML one would go to phase 3 in the second half of this year. I think this would be a big one if we catch it. The consolidation has been happening for a while.
MEIP expected to open at 5.39 for a Retest Gap. Be aware of low volume and low $ stock To learn to trade this strategy for free go to www.RealLifeTrading.com
